HaemaLogiX’s CMDO Tertia Dex to speak at 2nd Australia Biologics Festival 2024

HaemaLogiX is pleased to announce that our Chief Manufacturing and Development Officer, Tertia Dex, has been invited to speak at the 2nd Annual Australia Biologics Festival #ABF 2024 held February 20-21 in Melbourne.

Tertia will speak on ‘Ensuring cGMP Compliance in a Global Supply Chain’ at the event, which has a focus on key trends, opportunities and challenges in the biopharma industry in Australia and New Zealand and beyond.

Read IMAPAC's interview with Tertia about her presentation here. 

You can explore the event brochure where she shares key insights on the biomanufacturing industry.

More about the event here.